A Mathematical Model of TCR-T Cell Therapy for Cervical Cancer
From MaRDI portal
Publication:6496561
DOI10.1007/S11538-024-01261-9MaRDI QIDQ6496561
Heyrim Cho, Doron Levy, Zuping Wang, Noriko Sato, Peter L. Choyke
Publication date: 3 May 2024
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
PDEs in connection with biology, chemistry and other natural sciences (35Q92) Medical applications (general) (92C50) Qualitative investigation and simulation of ordinary differential equation models (34C60)
Cites Work
- Unnamed Item
- Mathematical modeling of regulatory T cell effects on renal cell carcinoma treatment
- Mathematical model creation for cancer chemo-immunotherapy
- Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer
- Identifying and characterising the impact of excitability in a mathematical model of tumour-immune interactions
- Emergent group dynamics governed by regulatory cells produce a robust primary T cell response
- Modeling immunotherapy of the tumor -- immune interaction
- Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
- The dynamics of an optimally controlled tumor model: A case study
- A time delay model of tumour-immune system interactions: global dynamics, parameter estimation, sensitivity analysis
- Ordinary differential equation models for adoptive immunotherapy
- An extended mathematical model of tumor growth and its interaction with the immune system, to be used for developing an optimized immunotherapy treatment protocol
- Mathematical modeling of tumor-immune cell interactions
- A mathematical model of tumor-immune interactions
- Mathematical modelling for the role of CD\(4^+\)T cells in tumor-immune interactions
- Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
- An immune system-tumour interactions model with discrete time delay: model analysis and validation
This page was built for publication: A Mathematical Model of TCR-T Cell Therapy for Cervical Cancer
